Bibliography: library/10665-43699

The reference for library/10665-43699 (who-iris) and any references extracted from it. library · All references.

Export these 78 references: BibTeX · CSL-JSON · RIS · Dublin Core XML · Dublin Core / BIBO JSON-LD

✍ + Add reference (standalone node)

Build a standalone folio-reference/v1 node at references/reference.jsonld from fields or pasted BibTeX / CSL-JSON.



· ✍ Create standalone node on GitHub · Download .jsonld · Download .csl.json ·

78 shown

  1. World Health Organization (2007). WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. World Health Organization.
    10665-43699 · catalogue · link · repository record · ISBN 9789241595629 · source: catalogue/records/10665-43699.dc.json · held: library/10665-43699
    export: BibTeX · RIS · CSL-JSON · DC XML
  2. World Health Organization. Workshop on AIDS in Africa 1986(WHO/CDS/AIDS.85.1).
    · extracted · source: references/10665-43699.sec-012.1.json
  3. [2] World Health Organization. Acquired Immunodeficiency syndrome (AIDS) WHO/CDC case definition for surveillance Weekly Epidemiological Record. 1986 7 March (10).
    · extracted · source: references/10665-43699.sec-012.2.json
  4. [3] World Health Organization. Acquired Immunodeficiency Syndrome. 1987 Revision of WHO/CDC case definition for AIDS. Weekly Epidemiological Record. 1988 1-8 January;63:1-8.
    · extracted · source: references/10665-43699.sec-012.3.json
  5. [4] Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep. 1987 Aug 14;36 Suppl 1:1S-15S.
    · extracted · source: references/10665-43699.sec-012.4.json
  6. [5] Revision of CDC/WHO case definition for acquired immunodeficiency syndrome (AIDS). Bull Pan Am Health Organ. 1988;22(2):195-201.
    · extracted · source: references/10665-43699.sec-012.5.json
  7. [6] World Health Organization. AIDS: 1987 revision of CDC/WHO case definition. Bull World Health Organ. 1988;66(2):259-63, 69-73.
    · extracted · source: references/10665-43699.sec-012.6.json
  8. [7] World Health Organization. WHO case definitions for AIDS surveillance in adults and adolescents Weekly Epidemiological Record. 1994 16 September;69:273.
    · extracted · source: references/10665-43699.sec-012.7.json
  9. [8] European AIDS case definition. Commun Dis Rep CDR Wkly. 1993 Jul 30;3(31):141.
    · extracted · source: references/10665-43699.sec-012.8.json
  10. [9] Effect of the 1993 European AIDS case definition in the United Kingdom. Commun Dis Rep CDR Wkly. 1994 Jan 14;4(2):5.
    · extracted · source: references/10665-43699.sec-012.9.json
  11. [10] Downs AM, Heisterkamp SH, Rava L, Houweling H, Jager JC, Hamers FF. Back-calculation by birth cohort, incorporating age- specific disease progression, pre-AIDS mortality and change in European AIDS case definition. European Union Concerted Action on Multinational AIDS Scenarios. AIDS. 2000 Sep 29;14(14):2179-89.
    · extracted · source: references/10665-43699.sec-012.10.json
  12. [11] Pezzotti P, Napoli PA, Rezza G, Lazzeri V, Acciai S, Curia R, et al. The effect of the 1993 European revision of the AIDS case definition in Italy: implications for modelling the HIV epidemic. AIDS. 1997 Jan;11(1):95-9.
    · extracted · source: references/10665-43699.sec-012.11.json
  13. [12] Verdecchia A, Grossi P, Cantoni M. The impact of the 1993 European revision of the AIDS case definition on back-calculation estimates: an application in Italy. Eur J Epidemiol. 1998 Jul;14(5):427-32.
    · extracted · source: references/10665-43699.sec-012.12.json
  14. [13] Chintu C, Malek A, Nyumbu M, Luo C, Masona J, DuPont HL, et al. Case definitions for paediatric AIDS: the Zambian experience. Int J STD AIDS. 1993 Mar-Apr;4(2):83-5.
    · extracted · source: references/10665-43699.sec-012.13.json
  15. [14] Keou FX, Belec L, Esunge PM, Cancre N, Gresenguet G. World Health Organization clinical case definition for AIDS in Africa: an analysis of evaluations. East Afr Med J. 1992 Oct;69(10):550-3.
    · extracted · source: references/10665-43699.sec-012.14.json
  16. [15] Lepage P, van de Perre P, Dabis F, Commenges D, Orbinski J, Hitimana DG, et al. Evaluation and simplification of the World Health Organization clinical case definition for paediatric AIDS. AIDS. 1989 Apr;3(4):221-5.
    · extracted · source: references/10665-43699.sec-012.15.json
  17. [16] Gulick RM, Ribaudo HJ, Shikuma CM, Lustgarten S, Squires KE, Meyer WA, 3rd, et al. Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. N Engl J Med. 2004 Apr 29;350(18):1850-61.
    · extracted · source: references/10665-43699.sec-012.16.json
  18. [17] Rouet F, Elenga N, Msellati P, Montcho C, Viho I, Sakarovitch C, et al. Primary HIV-1 infection in African children infected through breastfeeding. AIDS. 2002 Nov 22;16(17):2303-9.
    · extracted · source: references/10665-43699.sec-012.17.json
  19. [18] Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, et al. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Clin Immunol. 2001 Feb;98(2):212-9.
    · extracted · source: references/10665-43699.sec-012.18.json
  20. [19] De Rossi A. Primary HIV infection in infants: impact of highly active antiretroviral therapy on the natural course. J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):53-7.
    · extracted · source: references/10665-43699.sec-012.19.json
  21. [20] Kramer AB, R. J. Hampl, H. Friedman, R. M. Fuchs, D. Wachter, H. Goedert, J. J. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Am J Epidemiol. 1992 Jul 1;136(1):71-80 (0002-9262).
    · extracted · source: references/10665-43699.sec-012.20.json
  22. [21] Smith GH, Boulassel MR, Klien M, Gilmore N, MacLeod J, LeBlanc R, et al. Virologic and immunologic response to a boosted double-protease inhibitor-based therapy in highly pretreated HIV-1-infected patients. HIV Clin Trials. 2005 Mar-Apr;6(2):63-72.
    · extracted · source: references/10665-43699.sec-012.21.json
  23. [22] Soogoor M, Daar ES. Primary HIV-1 Infection: Diagnosis, Pathogenesis, and Treatment. Curr Infect Dis Rep. 2005 Mar;7(2):147-53.
    · extracted · source: references/10665-43699.sec-012.22.json
  24. [23] Kassutto S, Rosenberg ES. Primary HIV type 1 infection. Clin Infect Dis. 2004 May 15;38(10):1447-53.
    · extracted · source: references/10665-43699.sec-012.23.json
  25. [24] World Health Organization. Interim proposal for a WHO Staging System for HIV infection and disease. Weekly Epidemiological Record. 1990 20 July 65(29).
    · extracted · source: references/10665-43699.sec-012.24.json
  26. [25] World Health Organization. SCALING UP ANTIRETROVIRAL THERAPY IN RESOURCE-LIMITED SETTINGS:TREATMENT GUIDELINES FORA PUBLIC HEALTH APPROACH. 2003 [26] CDC. 1994 Revised classification system for human immunodeficiency virus infection in children <13 years of age. MMWR 1994;43(RR-12).
    · extracted · source: references/10665-43699.sec-012.25.json
  27. [27] Badri M, Maartens G, Wood R. Predictors and prognostic value of oral hairy leukoplakia and oral candidiasis in South African HIV-infected patients. South African Journal. 2001 Dec;56(12):592-6.
    · extracted · source: references/10665-43699.sec-012.26.json
  28. [28] Campo J, Del Romero J, Castilla J, Garcia S, Rodriguez C, Bascones A. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med. 2002 Jan;31(1):5-10.
    · extracted · source: references/10665-43699.sec-012.27.json
  29. [29] Dilys Morgan CM, Billy Mayanja, James A G Whitworth. Progression to symptomatic disease in people infected with HIV1 in rural Uganda: prospective cohort study. British Medical Journal. 2002 Jan 324:193–7.
    · extracted · source: references/10665-43699.sec-012.28.json
  30. [30] Dunn D. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet. 2003 Nov 15;362(9396):1605-11.
    · extracted · source: references/10665-43699.sec-012.29.json
  31. [31] Fahey J, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N. Engl J Med. 1990 Jun 28;322(26):1886.
    · extracted · source: references/10665-43699.sec-012.30.json
  32. [32] French N, Mujugira A, Nakiyingi J, Mulder D, Janoff EN, Gilks CF. Immunologic and clinical stages in HIV-1-infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease. J Acquir Immune Defic Syndr. 1999 Dec 15;22(5):509-16.
    · extracted · source: references/10665-43699.sec-012.31.json
  33. [33] Malamba SSM, D. Clayton, T. Mayanja, B. Okongo, M. Whitworth, J. The prognostic value of the World Health Organisation staging system for HIV infection and disease in rural Uganda. 1999;AIDS(13):2555-62.
    · extracted · source: references/10665-43699.sec-012.32.json
  34. [34] Stein DS, Lyles RH, Graham NM, Tassoni CJ, Margolick JB, Phair JP, et al. Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: a comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and beta2-microglobulin. Multicenter AIDS Cohort Study. J Infect Dis. 1997 Nov;176(5):1161-7.
    · extracted · source: references/10665-43699.sec-012.33.json
  35. [35] Whittle H Egboga A, Todd J, Corrah T, Wilkins A, Demba E, Morgan G, et al. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. AIDS 1992 Jul;6(7):685-9.
    · extracted · source: references/10665-43699.sec-012.34.json
  36. [36] Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997 Jun [37] Bonnet F, Thiebaut R, Chene G, Neau D, Pellegrin JL, Mercie P, et al. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002. HIV Med. 2005 May;6(3):198-205.
    · extracted · source: references/10665-43699.sec-012.35.json
  37. [38] Taha TE, Graham SM, Kumwenda NI, Broadhead RL, Hoover DR, Markakis D, et al. Morbidity among human immunodeficiency virus-1-infected and -uninfected African children. Pediatrics. 2000 Dec;106(6):E77.
    · extracted · source: references/10665-43699.sec-012.36.json
  38. [39] O’Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med. 1997 Jun 15;126(12):939-45.
    · extracted · source: references/10665-43699.sec-012.37.json
  39. [40] Hogg R, Yip B, Chan KJ, Wood E, Craib KJ, O’Shaughnessy MV, Montaner JS, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. (0098-7484). [41] Grabar S, Le Moing V, Goujard C, Egger M, Leport C, Kazatchkine MD, et al. Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):284-92.
    · extracted · source: references/10665-43699.sec-012.38.json
  40. [42] Breton G, Duval X, Estellat C, Poaletti X, Bonnet D, Mvondo Mvondo D, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis. 2004 Dec 1;39(11):1709-12.
    · extracted · source: references/10665-43699.sec-012.39.json
  41. [43] Buckingham SJ, Haddow LJ, Shaw PJ, Miller RF. Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy. Clin Radiol. 2004 Jun;59(6):505-13.
    · extracted · source: references/10665-43699.sec-012.40.json
  42. [44] Goebel FD. Immune reconstitution inflammatory syndrome (IRIS)--another new disease entity following treatment initiation of HIV infection. Infection. 2005 Feb;33(1):43-5.
    · extracted · source: references/10665-43699.sec-012.41.json
  43. [45] Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K, Dromer F. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS. 2005 Jul 1;19(10):1043-9.
    · extracted · source: references/10665-43699.sec-012.42.json
  44. [46] Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC, Jr., et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005 Mar 4;19(4):399-406.
    · extracted · source: references/10665-43699.sec-012.43.json
  45. [47] Nishanian P, Taylor JM, Manna B, Aziz N, Grosser S, Giorgi JV, Detels R, et al. Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset. (1077-9450). J Acquir Immune Defic Syndr. 1998 Jan 7;279(1):35-40.
    · extracted · source: references/10665-43699.sec-012.44.json
  46. [48] MacDonell Kb - Chmiel JS, Poggensee L, Wu S, Phair JP. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. (0002-9343). Hum Retroviral. 1998 Jan 7;279(1):35-40.
    · extracted · source: references/10665-43699.sec-012.45.json
  47. [49] Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997 Jan 15;126(12):946-54.
    · extracted · source: references/10665-43699.sec-012.46.json
  48. [50] PENTA. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA). Jan 1;18(2):162-70 (0269-9370). [51] Vajpayee M, Kaushik S, Sreenivas V, Wig N, Seth P. CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1-infected Indian population: treatment implications. Clinical and Experimental Immunology. 2005;141(3):485-90.
    · extracted · source: references/10665-43699.sec-012.47.json
  49. [52] Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. Jama. 1998 Jan 7;279(1):35-40.
    · extracted · source: references/10665-43699.sec-012.48.json
  50. [53] Bunders M, Cortina-Borja M, Newell ML. Age-related standards for total lymphocyte, CD4+ and CD8+ T cell counts in children born in Europe. Pediatr Infect Dis J. 2005 Jul;24(7):595-600.
    · extracted · source: references/10665-43699.sec-012.49.json
  51. [54] Carey VJ, Pahwa S, Weinberg A. Reliability of CD4 quantitation in human immunodeficiency virus-positive children: implications for definition of immunologic response to highly active antiretroviral therapy. Clin Diagn Lab Immunol. 2005 May;12(5):640-3.
    · extracted · source: references/10665-43699.sec-012.50.json
  52. [55] Mofenson LM, Harris DR, Moye J, Bethel J, Korelitz J, Read JS, et al. Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings. Lancet. 2003 Nov 15;362(9396):1625-7.
    · extracted · source: references/10665-43699.sec-012.51.json
  53. [56] Ochieng W, Ogoyi D, Mulaa FJ, Ogola S, Musoke R, Otsyula MG. Viral load, CD4+ T-lymphocyte counts and antibody titres in HIV-1 infected untreated children in Kenya; implication for immunodeficiency and AIDS progression. Afr Health Sci. 2006 Mar;6(1):3-13.
    · extracted · source: references/10665-43699.sec-012.52.json
  54. [57] Shah I. Correlation of CD4 count, CD4% and HIV viral load with clinical manifestations of HIV in infected Indian children. Ann Trop Paediatr. 2006;26(2):115-9.
    · extracted · source: references/10665-43699.sec-012.53.json
  55. [58] van Benthem BH VP, Coutinho RA, Prins M,. European Study on the Natural History of HIV Infection in Women and the Swiss HIV Cohort Study. AIDS. 2002;16(6)(Apr 12):919-24.
    · extracted · source: references/10665-43699.sec-012.54.json
  56. [59] Waecker NJ, Jr., Ascher DP, Robb ML, Moriarty R, Krober M, Rickman WJ, et al. Age-adjusted CD4+ lymphocyte parameters in healthy children at risk for infection with the human immunodeficiency virus. The Military Pediatric HIV Consortium. Clin Infect Dis. 1993 Jul;17(1):123-5.
    · extracted · source: references/10665-43699.sec-012.55.json
  57. [60] 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19.
    · extracted · source: references/10665-43699.sec-012.56.json
  58. [61] Chearskul S, Chotpitayasunondh T, Simonds RJ, Wanprapar N, Waranawat N, Punpanich W, et al. Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics. 2002 Aug;110(2 Pt 1):e25.
    · extracted · source: references/10665-43699.sec-012.57.json
  59. [62] Johnston AM, Valentine ME, Ottinger J, Baydo R, Gryszowka V, Vavro C, Weinhold K, et al. Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study. (0891-3668). Pediatr Infect Dis J. 2001 Oct;20(10):941-6.
    · extracted · source: references/10665-43699.sec-012.58.json
  60. [63] Ghaffari G, Passalacqua DJ, Caicedo JL, Goodenow MM, Sleasman JW. Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy. Pediatrics. 2004 Nov;114(5):e604-11.
    · extracted · source: references/10665-43699.sec-012.59.json
  61. [64] Newell ML, Patel D, Goetghebuer T, Thorne C. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis. 2006 Apr 1;193(7):954-62.
    · extracted · source: references/10665-43699.sec-012.60.json
  62. [65] Resino S, Bellon JM, Ramos JT, Resino R, Gurbindo MD, Mellado MJ, et al. Impact of highly active antiretroviral therapy on CD4+ T cells and viral load of children with AIDS: a population-based study. AIDS Res Hum Retroviruses. 2004 Sep;20(9):927-31.
    · extracted · source: references/10665-43699.sec-012.61.json
  63. [66] Nikolic-Djokic D, Essajee S, Rigaud M, Kaul A, Chandwani S, Hoover W, et al. Immunoreconstitution in children receiving highly active antiretroviral therapy depends on the CD4 cell percentage at baseline. J Infect Dis. 2002 Feb 1;185(3):290-8.
    · extracted · source: references/10665-43699.sec-012.62.json
  64. [67] Cohen Stuart JW, Slieker WA, Rijkers GT, Noest A, Boucher CA, Suur MH, et al. Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infections. Aids. 1998 Nov 12;12(16):2155-9.
    · extracted · source: references/10665-43699.sec-012.63.json
  65. [68] Uppal SS, Tewari SC, Verma S, Dhot PS. Comparison of CD4 and CD8 lymphocyte counts in HIV-negative pulmonary TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study. Cytometry B Clin Cytom. 2004 Sep;61(1):20-6.
    · extracted · source: references/10665-43699.sec-012.64.json
  66. [69] Jiang W, Kang L, Lu HZ, Pan X, Lin Q, Pan Q, et al. Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai. Clin Diagn Lab Immunol. 2004 Jul;11(4):811-3.
    · extracted · source: references/10665-43699.sec-012.65.json
  67. [70] Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004 May;112(1):38-43.
    · extracted · source: references/10665-43699.sec-012.66.json
  68. [71] Uppal SS, Verma S, Dhot PS. Normal values of CD4 and CD8 lymphocyte subsets in healthy indian adults and the effects of sex, age, ethnicity, and smoking. Cytometry B Clin Cytom. 2003 Mar;52(1):32-6.
    · extracted · source: references/10665-43699.sec-012.67.json
  69. [72] Ramalingam S, Kannangai R, Zachariah A, Mathai D, Abraham C. CD4 counts of normal and HIV-infected south Indian adults: do we need a new staging system? Natl Med J India. 2001 Nov-Dec;14(6):335-9.
    · extracted · source: references/10665-43699.sec-012.68.json
  70. [73] Kannangai R, Prakash KJ, Ramalingam S, Abraham OC, Mathews KP, Jesudason MV, et al. Peripheral CD4+/CD8+ T-lymphocyte counts estimated by an immunocapture method in the normal healthy south Indian adults and HIV seropositive individuals. J Clin Virol. 2000 Aug;17(2):101-8.
    · extracted · source: references/10665-43699.sec-012.69.json
  71. [74] Fernandez S, Rosenow AA, James IR, Roberts SG, Nolan RC, French MA, et al. Recovery of CD4+ T Cells in HIV patients with a stable virologic response to antiretroviral therapy is associated with polymorphisms of interleukin-6 and central major histocompatibility complex genes. J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):1-5.
    · extracted · source: references/10665-43699.sec-012.70.json
  72. [75] Brigido L, Rodrigues R, Casseb J, Custodio RM, Fonseca LA, Sanchez M, et al. CD4+ T-cell recovery and clinical outcome in HIV-1-infected patients exposed to multiple antiretroviral regimens: partial control of viremia is associated with favorable outcome. AIDS Patient Care STDS. 2004 Apr;18(4):189-98.
    · extracted · source: references/10665-43699.sec-012.71.json
  73. [76] Bennett KK, DeGruttola VG, Marschner IC, Havlir DV, Richman DD. Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):20-6.
    · extracted · source: references/10665-43699.sec-012.72.json
  74. [77] Viard JP, Mocroft A, Chiesi A, Kirk O, Roge B, Panos G, et al. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis. 2001 Apr 15;183(8):1290-4.
    · extracted · source: references/10665-43699.sec-012.73.json
  75. [78] Franco JM, Leon-Leal JA, Leal M, Cano-Rodriguez A, Pineda JA, Macias J, et al. CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol. 2000 Mar;119(3):493-8.
    · extracted · source: references/10665-43699.sec-012.74.json
  76. [79] Mellors JM, A. Giorgi, J. V. Margolick, J. B. Tassoni, C. J. Gupta, P. Kingsley, L. A. Todd, J. A. Saah, A. J. Detels, R. Phair, J. P. Rinaldo, C. R., Jr. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997 Jun [80] Lafeuillade A, Tamalet C, Pellegrino P, de Micco P, Vignoli C, Quilichini R,. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
    · extracted · source: references/10665-43699.sec-012.75.json
  77. (0894-9255). [81] Mellors JW, Rinaldo CR, Jr., Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996 May 24;272(5265):1167-70.
    · extracted · source: references/10665-43699.sec-012.76.json
  78. [82] Temmerman M NN, Bwayo J, Chomba EN, Ndinya-Achola J, Piot P. HIV-1 and immunological changes during pregnancy: a comparison between HIV-1-seropositive and HIV-1-seronegative women in Nairobi, Kenya. AIDS. 1995 Sep;9(9):1057-60.
    · extracted · source: references/10665-43699.sec-012.77.json